The global valvular heart diseases market is anticipated to grow at a considerable CAGR of around 8.0% during the forecast period (2024-2031). Valvular heart disease is categorized by deficiency or any damage in one of the four heart valves, namely, aortic, tricuspid or pulmonary, and mitral. Adult cardiac surgery such as treatment for valvular heart diseases is growing at a rapid pace. Valvular heart disease can be diagnosed by chest x-ray, electrocardiogram, cardiac catheterization, stress testing, and other diagnosis procedure. Valvular heart disease can be treated by medication or surgery. The major factor that drives the growth of the market includes the increasing prevalence of coronary artery diseases, cardiovascular diseases, and heart attack. The change in lifestyle, obesity and extreme consumption of alcohol boost the market growth. Additionally, according to the World Health Organization (WHO), cardiovascular disease is one of the main reasons for mortality across the globe. CVDs cause around 17.9 million deaths across the globe each year.
Get Free Sample link @ https://www.omrglobal.com/request-sample/valvular-heart-diseases-treatment-market
Moreover, to gain major market share in the market the key players operating in the global valvular heart diseases market had been adopting strategies such as product expansion, drug launch, and the US FDA approval. For instance, In December 2019, CryoLife, Inc. had received approval from the US Food and Drug Administration (FDA) for Investigational New Drug (IND) application to initiate the PROACT Xa clinical trial, The trial is to regulate if patients with an On-X mechanical aortic valve can be sustained safely and efficiently on apixaban rather than warfarin.
Full report of Valvular Heart Diseases Market available @ https://www.omrglobal.com/industry-reports/valvular-heart-diseases-treatment-market
Market Coverage
- Segment Covered-
o By Diseases
o By Diagnosis
o ByTreatment
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape – Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corp., CryoLife, Inc., Edwards Lifesciences Corp., Medtronic, Plc, Siemens Healthcare Medical Solutions Ltd.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Valvular Heart Diseases Market
By Diseases
- Aortic Valve Replacement
- Heart Valve Disease
- Mitral Valve Stenosis
- Others (Tricuspid Valve Disorders)
By Diagnosis
- Cardiac Catheterization
- Electrocardiogram (ECG)
- Chest X-Ray
- Stress Testing
- Others
By Treatment
- Medication
- Surgery
By End-User
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/valvular-heart-diseases-treatment-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
